2Diener HC, Dodick DW. Headache research in 2015: progress in migraine treatment[J]. Lancet Neurol, 2016, 15 (1) : 4-5.
3Amin FM, Hougaard A, Magon S, et al. Change in brain network connectivity during PACAP38-induced migraine attacks: A resting-state functional MRI study[J]. Neurology, 2016, 86 (2) :180- 187.
4Fiala JL, Lowery D. Patent watch: Migraine therapies targeting the CGRP pathway: intellectual property landscape[J]. Nat Rev Drug Discov, 2016, 15(1) :8-9.
5Sabri MR, Dehghan B, Yaghini O, et al. Endothelial dysfunction state in migraine headache and neutrally mediated syncope in children and young adults[J]. JRes Med Sci, 2015, 20 (8) : 771-776.
6Adam Stepiefl. Headache classification subcommittee of the inter- national headache society. The international classification of head- ache disorders, 2nd edn. Cephalalgia 2004; 24 Suppl. 1:1-160[J]. Neurologia 1Neurochirurgia Polska, 2004, 24 (1) : 9 160.
7Irby MB, Bond DS, Lipton RB, et al. Aerobic exercise for reducing migraine burden" mechanisms, markers, and models of change processes[J]. Headache, 2016, 56 (2) : 357-369.
8Noruzzadeh R, Modabbernia A, Aghamollaii V, et al. Memantine for prophylactic treatment of migraine without aura: a randomized double blind placebo-controlled study[J]. Headache, 2016, 56 (1) :95-103.
9McDermott M J, Fulwiler JC, Smitherman TA, et al. The relation of PTSD symptoms to migraine and headache-related disability among substance dependent inpatients[J]. J Behav Med, 2016, 39 (2) : 300- 309.
10Kilit C, Oruc S, Kilit TP, et al. The effect of zolmitriptan on cardiac autonomic modulation in patients with migraine: A double-blind, placebo-controlled, crossover study[J]. Neurol India, 2015,63 (6) : 860-865.
